We empower access to medicines on a global level.
Using our experience, regulatory expertise and network of suppliers from over 40 countries, we provide access to over 87% of the world health system from our distribution hubs in the EU, UK, Dubai, India and more.
We partner with healthcare professionals, pharmaceutical & biotech companies, wholesalers & distributors, aid organizations and patients to ensure access to medicines.
From regulatory analysis to strategic plans, procurement and delivery, we provide best-in-class programs and services.
Over two decades of focused expertise.
Aid & Development
We partner with NGOs, charities and multi-lateral organizations to provide pharmaceuticals, medical disposables, medical equipment and hospital and doctors’ furniture.
Comparator/RLD Supply
We support manufacturers, CROs and CDMOs with supply of comparator, RLDs, samples and biosimilar samples.
Early Access Programs (EAP)
We’ll partner with innovative Pharma and Biotech companies to design and manage global Early Access, Expanded Access, Named Patient and Compassionate Use Programs.
Hospital & Pharmacy Supply
Thanks to our global sourcing network, we supply products that are in shortage, unlicensed medicines, imported medicines, specials, and not yet launched medicines to hospitals, pharmacies and globally.
International Supply & Unlicensed Imports
We source and distribute on a global basis, supplying branded and generic pharmaceuticals not otherwise available in your country. We also supply a range of unlicensed medicines to hospitals and healthcare professionals in the UK, UAE and globally.
Sexual Health Supply
We support UK hospitals and sexual health clinics with pharmaceuticals and medical disposables.
Specialist Distribution
We work with Pharma and Biotech companies to deliver specialist distribution services. We operate in therapeutic and geographic areas that need specialist expertise.
What’s new at Smartway
02 February 2026
News
Smartway Pharmaceuticals Welcomes Paul Kohler MPSmartway Pharmaceuticals welcomed Paul Kohler MP to its headquarters in South Wimbledon in January 2026, where he spent time with senior members of our team discussing how we support access to medicines across the UK and internationally. The visit provided an opportunity to explore how Smartway operates across public and private healthcare systems,...
13 November 2025
News
Parallel Imported Medicines: Strengthening Access, Affordability, and Resilience in Modern HealthcareMedicine shortages are becoming more frequent, impacting patients everywhere. The Royal Pharmaceutical Society (RPS) has stated that “Medicines shortages impair patients’ access to treatment, causing frustration, anxiety and in some cases worsening health”.1 The RPS report also highlighted “There is a growing consensus that the increase in medicines shortages that the...
02 May 2025
News
Introducing SmartMed: Smartway’s New Portal for Unlicensed MedicinesSupporting Access, Enhancing Safety For over two decades, Smartway has been supporting the NHS, private hospitals, pharmacies and clinics with the reliable supply of unlicensed medicines, particularly during times of medicine shortages and disruptions. Our expertise in sourcing and supplying unlicensed medicines has helped ensure continuity of care for patients when licensed alternatives are unav...